Profound Medical Income Statement

Financials in millions CAD. Fiscal year is January - December.

Millions CAD. Fiscal year is Jan - Dec.

Year	2023	2022	2021	2020	2019	2018	2017	2016
Revenue	7.2	6.68	6.87	7.3	4.17	2.6	4.9	0
Revenue Growth (YoY)	7.75%	-2.79%	-5.90%	74.99%	60.40%	-46.94%	-	-
Cost of Revenue	2.82	3.66	3.92	3.83	1.78	1.78	3.03	0
Gross Profit	4.38	3.02	2.95	3.47	2.39	0.82	1.87	0
Selling, General & Admin	18.62	17.93	17.97	12.43	7.9	10.75	9.86	5.65
Research & Development	14.38	14.69	15.28	9.91	9.4	10.27	9.64	9.99
Other Operating Expenses	0	2.52	0	0	0	0	0	0
Operating Expenses	33	35.15	33.24	22.34	17.29	21.01	19.5	15.64
Operating Income	-28.62	-32.13	-30.29	-18.86	-14.9	-20.19	-17.63	-15.64
Interest Expense / Income	0.08	-3.74	0.3	2.71	0.17	0.83	1.25	0.83
Other Expense / Income	4.81	-12.09	-0.18	2.8	4.49	-0.45	-0.13	-0.16
Pretax Income	-33.5	-16.29	-30.42	-24.38	-19.57	-20.56	-18.75	-16.31
Income Tax	-0.13	0.29	0.11	0.05	0.15	0.23	0.07	0.01
Net Income	-33.38	-16.58	-30.52	-24.42	-19.71	-20.79	-18.82	-16.33
Shares Outstanding (Basic)	21	21	21	20	12	12	-	-
Shares Change	2.35%	0.51%	5.83%	65.58%	-	-	-	-
EPS (Basic)	-1.35	-1.38	-1.50	-1.25	-1.37	-2.07	-0.31	-0.39
EPS (Diluted)	-1.35	-1.38	-1.50	-1.25	-1.37	-2.07	-0.31	-0.39
Free Cash Flow	-22.3	-25.8	-22.39	-20.57	-15.05	-18.29	-16	-15.37
Free Cash Flow Per Share	-1.04	-1.24	-1.08	-1.05	-1.27	-1.54	-	-
Gross Margin	60.87%	45.22%	42.95%	47.56%	57.26%	31.66%	38.18%	-
Operating Margin	-397.50%	-480.86%	-440.72%	-258.26%	-357.07%	-775.85%	-359.40%	-
Profit Margin	-463.61%	-248.14%	-444.06%	-334.39%	-472.26%	-799.00%	-383.77%	-
Free Cash Flow Margin	-309.72%	-386.17%	-325.80%	-281.68%	-360.57%	-703.02%	-326.26%	-
EBITDA	-32.28	-18.43	-28.23	-20.13	-17.88	-18.06	-16.63	-15.3
EBITDA Margin	-448.34%	-275.87%	-410.78%	-275.56%	-428.44%	-694.03%	-339.02%	-
Depreciation & Amortization	1.15	1.6	1.88	1.54	1.51	1.67	0.87	0.19
EBIT	-33.42	-20.04	-30.11	-21.67	-19.39	-19.74	-17.5	-15.48
EBIT Margin	-464.26%	-299.88%	-438.12%	-296.62%	-464.64%	-758.38%	-356.79%	-

Source: Financials are provided by Nasdaq Data Link and sourced from audited reports submitted to the Securities and Exchange Commission (SEC).